1 |
Kanning, K. C., A. Kaplan, and C. E. Henderson (2010) Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 3: 409-440.
|
2 |
Bradley, W. (1996) Overview of motor neuron disease: classification and nomenclature. Clin. Neurosci. 3: 323-326.
|
3 |
Fiszman, M. L., L. N. Borodinsky, K. C. Ricart, O. P. Sanz, and R. E. Sica (1999) Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 162: 34-37.
DOI
ScienceOn
|
4 |
Pramatarova, A., D. A. Figlewicz, A. Krizus, F. Y. Han, P. I. Ceballos, A. Nicole, M. Dib, V. Meininger, and R. H. Brown (1995) Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 56: 592-596.
|
5 |
Millecamps, S., F. Salachas, C. Cazeneuve, P. Gordan, B. Bricka, A. Camuzat, L. N. Guillot, O. Russaouen, G.. Bruneateau, P. F. Pradat, N. Le-Forestier, V. Danel-Brunaud, N. Guy, R. C. Thauvin, L. Lacomblez, P. Cauratier, D. Hannequin, D. Seilhean, I. Ler-Ber, P. Corcia, W. Camu, A. Brice, G. Rouleau, E. LeGuern, and V. Meininger (2010) SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: Genotype-phenotype correlations. J. Med. Genet. 47: 554-560.
DOI
|
6 |
Ross, C. A., and M. A. Poirier (2004) Protein aggregation and neurodegenerative disease. Nat. Med. 10: S10-17.
DOI
ScienceOn
|
7 |
Mackenzie, I. R., R. Rademakers, and M. Neumann (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet. Neurol. 9: 995-1007.
DOI
ScienceOn
|
8 |
Lefebvre, S., L. Burglen, S. Reboullet, O. Clermont, P. Burlet, L. Viollet, B. Benichou, C. Cruaud, P. Millasseau, M. Zeviani, et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165
DOI
ScienceOn
|
9 |
Hanna, K. M., L. Tuovinen, S. Penttila, T. Suominen, B. Udd, and J. Palmio (2012) TARDBP mutations are not a frequent cause of ALS in Finnish patients. Acta. Myol. 31: 134-138.
|
10 |
Snowden, J. S., S. Rollinson, J. C. Thompson, J. M. Harris, C. L. Stopford, A. M. Richardson, M. Jones, A. Gerhard, Y. S. Davidson, A. Robinson, L. Gibbons, Q. Hu, D. DuPlessis, D. Neary, D. M. Mann and S. M. Pickering-Brown (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135: 693-708.
DOI
|
11 |
Talbot, K. (2002) Motor neurone disease. Postgrad. Med. J. 78: 513-519.
DOI
|
12 |
Siddharthan, C. and S. Andrea (2011) The use of stem cells in Motor Neurone Disease (MND), Adv. Clin. Neurosci. Rehabil. 11: 10-11.
|
13 |
Oliveira, A. S. B. and R. D. B. Pereira (2009) Amyotrophic lateral sclerosis (ALS): Three letters that change the people's life. For ever. Arq. Neuropsiquiatr. 67: 750-782.
DOI
|
14 |
Henny, N., W. Shane, A. Michal, B. Shlomo, and Weil, Miguel (2012) Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadicamyotrophic lateral sclerosis. Dis. Markers 32: 211-220.
DOI
|
15 |
Hima, B. A. and B. Srilatha (2011) Potency of various types of stem cells and their transplantation. J. Stem Cell Res. Ther. 1: 115.
|
16 |
Wichterle, H., I. Lieberam, J. A. Porter, and T. M. Jessell (2002) Directed differentiation of embryonic stem cells into motor neurons. Cell 110: 385-397.
DOI
ScienceOn
|
17 |
Takahashi, K. and S. Yamanaka (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 4: 663-676.
|
18 |
Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
DOI
ScienceOn
|
19 |
Paspala, S. A., A. B. Balaji, P. Nyamath, K. S. Ahmed, A. A. Khan, M. N. Khaja,M. L. Narsu, Y. P. Devi, T. V. Murthy, and C. M. Habibullah (2009) Neural stem cells & supporting cells-the new therapeutic tools for the treatment of spinal cord injury. Indian. J. Med. Res. 30: 379-391.
|
20 |
Deshpande. D. M., Y. S. Kim, T. Martinez, J. Carmen, S. Dike, I. Shats, L. L. Rubin, J. Drummond, C. Krishnan, A. Hoke, N. Maragakis, J. Shefner, J. D. Rothstein, and D. A. Kerr (2006) Recovery from paralysis in adult rats using embryonic stem cells. Ann. Neurol. 60: 32-44.
DOI
ScienceOn
|
21 |
Daadi, M. M., B. A. Grueter, R. C. Malenka, D. E. Redmond, and G. K. Steinberg (2012) Dopaminergic neurons from midbrainspecified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of parkinson's disease. PLoS ONE 7: e41120.
DOI
|
22 |
Svitlana, G. D., E. W. Alison, Z. Tanja, S. Saporta, B. J. Eleanor, J. C. Lane, J. E. Hudson, N. Chen, C. D. Davis, and P. R. Sanberg (2003) Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J. Hematother. Stem Cell Res. 12: 255-270.
DOI
ScienceOn
|
23 |
Garbuzova-Davis, S., M. C. O. Rodrigues, S. Mirtyl, S. Turner, S. Mitha, J. Sodhi, S. Suthakaran, D. J. Eve, C. D. Sanberg, N. N. Kuzmin, and P. R. Sanberg (2012) Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS. PLoS ONE 7: e31254.
DOI
|
24 |
Hofstetter, C. P., J. P. Card, and L. A. Olson (2005) A spinal cord pathway connecting primary afferents to the segmental sympathetic outflow system. Exp. Neurol. 194: 128-138.
DOI
ScienceOn
|
25 |
Gonzalez-Garza, M. T., H. R. Martinez, E. Caro-Osorio, D. E. Cruz-Vega, M. Hernandez-Torre, and J. E. Moreno-Cuevas (2013) Differentiation of CD133+ stem cells from amyotrophic lateral sclerosis patients into preneuron cells. Stem Cells Transl. Med. 2: 129-135.
DOI
|
26 |
Corti, S., F. Locatelli, D. Papadimitriou, C. Donadoni, R. Del Bo, M. Crimi, A. Bordoni, F. Fortunato, S. Strazzer, G. Menozzi, S. Salani, N, Bresolin, and G. P. Comi (2006) Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum. Mol. Genet. 15: 167-187.
DOI
|
27 |
Einstein, O. and T. Ben-Hur (2008) The changing face of neural stem cell therapy in neurologic diseases. Arch. Neurol. 65: 452-456.
DOI
ScienceOn
|
28 |
Ryu, M. Y., M. A. Lee, Y. H. Ahn, K. S. Kim, S. H. Yoon, E. Y. Snyder, K. G. Cho, S. U. Kim (2005) Brain transplantation of genetically modified neural stem cells in parkinsonian rat. Cell Transplant. 14: 193-202.
DOI
ScienceOn
|
29 |
Kim, S. U., I. H. Park, T. H. Kim, K. S. Kim, H. B. Choi, S. H. Hong, J. H. Bang, M. A. Lee, I. S. Joo, K. S. Lee, and K. S. Kim (2006) Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 26: 129-140.
DOI
ScienceOn
|
30 |
Kim, S. U. and J. de Vellis (2009) Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 87: 2183-2200.
DOI
ScienceOn
|
31 |
Lindvall, O. and Z. Kokaia (2010) Stem cells in human neurodegenerative disorders-time for clinical translation? J. Clin. Invest. 120: 29-40.
DOI
ScienceOn
|
32 |
Corti, S., M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, R. Del Bo, D. Papadimitriou, F. Locatelli, N. Mezzina, F. Gianni, N. Bresolin, G. P. Comi (2009) Motoneuron transplantation rescues the phenotype of SMARD1 (spinal muscular atrophy with respiratory distress type 1). J. Neurosci. 29: 11761-11771.
DOI
ScienceOn
|
33 |
Gowing, G., and C. N. Svendsen (2011) Stem cell transplantation for motor neuron disease: current approaches and future perspectives. Neurotherapeutics.8: 591-606.
DOI
|
34 |
Benkler, C., D. Offen, E. Melamed, L. Kupershmidt, T. Amit, S. Mandel, M. B. H. Youdim, and O. Weinreb (2010) Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application. EPMA J. 2: 343-361.
|
35 |
Suzuki, M., J. McHugh, C. Tork, B. Shelley, S. M. Klein, P. Aebischer, and C. N. Svendsen (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PloS One. 2: e689.
DOI
|
36 |
Hwang, D. H., B. G. Kim, E. J. Kim, S. I. Lee, I. S. Joo, H. S. Kim, S. Sohn, and S. U. Kim (2009) Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury. BMC Neurosci. 10: 117-132.
DOI
ScienceOn
|
37 |
Henriques, A., C. Pitzer, and A. Schneider (2010) Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front Neurosci. 4: 32-45.
|
38 |
Yu, J., M. A. Vodyanik, O. K. Smuga, J. Antosiewicz-Bourget, J. L. Frane, S. Tian, J, Nie, G. A. Jonsdottir, V. Ruotti, R. Stewart, I. I. Slukvin, and J. A. Thomson (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science. 318: 1917-1920.
DOI
ScienceOn
|
39 |
Park, I. H., R. Zhao, J. A. West, A. Yabuuchi, H. Huo, T. A. Inca, P. H. Lerou, M. W. Lensch, and G. Q. Daley (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 451: 141-146.
DOI
ScienceOn
|
40 |
Alipio, Z., W. Liao, E. J. Roemer, M. Waner, L. M. Fink, D. C. Ward, and Y. Ma (2010) Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl. Acad. Sci. USA 107: 13426-13431.
DOI
ScienceOn
|
41 |
Hanna, J., M. Wernig, S. Markoulaki, C. W. Sun, A. Meissner, J. P. Cassady, C. Beard, T. Brambrink, L. C. Wu, T. M. Townes, and R. Jaenisch (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
DOI
ScienceOn
|
42 |
Tsuji, O., K. Miura, Y. Okada, K. Fujiyoshi, M. Mukaino, N. Nagoshi, K. Kitamura, G, Kumagai, M. Nishino, S. Tomisato, H, Higashi, T, Nagai, H, Katoh, K. Kohda, Y. Matsuzaki, M. Yuzaki, E. Ikeda, Y. Toyama, M. Nakamura, S. Yamanaka, and H. Okano (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. USA 107: 12704-12709.
DOI
ScienceOn
|
43 |
Wernig, M., J. P. Zhao, J. Pruszak, E. Hedlund, D. Fu, F. Soldner, V. Broccoli, M. Constantine-Paton, O. Isacson, and R. Jaenisch (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105(15): 5856-5861.
|
44 |
Xu, D., Z. Alipio, L. M. Fink, D. M. Adcock, J. Yang, D. C. Ward, and Y. Ma (2009) Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. USA 106: 808-813.
DOI
ScienceOn
|
45 |
Egawa, N., S. Kitaoka, K. Tsukita, M. Naitoh, K. Takahashi, T. Yamamoto, F. Adachi, T. Kondo, K. Okita, I. Asaka, T. Aoi, A. Watanabe, Y. Yamada, A. Morizane, J. Takahashi, T. Ayaki, H. Ito, K, Yoshikawa, S. Yamawaki, S. Suzuki, D. Watanabe, H. Hioki, T. Kaneko, K. Makioka, K. Okamoto, H. Takuma, A. Tamaoka, K. Hasegawa, T. Nonaka, M. Hasegawa, A. Kawata, M. Yoshida, T. Nakahata, R. Takahashi, M.C. Marchetto, F. H. Gage, S. Yamanaka, and H. Inoue (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 4: 145-153.
|
46 |
Kelly, H. (2002) Ten problems with embryonic stem cell research. Acts & Facts. 31: 2-5.
|